Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-14

FDA Approved: LOSARTAN POTASSIUM — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approves the original application for losartan potassium (a generic product) by Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

ORIG AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)